Ocular blood flow biomarkers may predict long-term glaucoma progression
British Journal of Ophthalmology · 2024
DOI: 10.1136/bjo-2022-322644 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Ophthalmology, 2024. Verfasst von Alice Chandra Verticchio Vercellin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Hauptthemen laut MEDLINE: Disease Progression, Glaucoma, Open-Angle, Tomography, Optical Coherence, Intraocular Pressure. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NEI NIH HHS, NIH, NYEE Foundation.
Abstract (Originalsprache)
Background/aim To examine the relationship between baseline blood flow biomarkers and long-term open-angle glaucoma (OAG) progression.
Methods
112 patients with early to moderate OAG (mean age 64.9±11.0 years; 68 female) were evaluated at baseline and every 6 months from 2008 to 2013. Biomarkers of retinal capillary blood flow were assessed by Heidelberg retinal flowmetry. Functional disease progression was monitored via Humphrey visual field examinations, defined as two consecutive visits with a mean deviation decrease ≥2 decibels and/or Advanced Glaucoma Intervention Study score increase ≥2 compared with baseline. Structural progression was monitored with optical coherence tomography and Heidelberg retinal tomograph, defined as two consecutive visits with retinal nerve fibre layer thickness decrease ≥8% and/or horizontal or vertical cup/disk ratio increase ≥0.2 compared with baseline. Mixed-model analysis of covariance was used to test for significant change from baseline to 5-year follow-up. Times to functional and structural progression were analysed using Cox proportional hazards models.
Results
Lower HRF retinal capillary blood flow in the superior retina was significantly associated with structural progression (p=0.0009).
Conclusion
In our OAG sample, baseline lower retinal capillary perfusion in the superior retina was predictive of structural progression after 5 years. Trial registration number NCT01145911 .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, New York, USA palonharris@gmail.com.
- Glaucoma Unit, IRCCS Fondazione G.B.Bietti, Rome, Italy.
- Department of Biostatistics abd Health Data Science, Indiana University School of Medicine and Richard M. Fairbanks School of Public Health, Indianapolis, Indiana, USA.
- Ophthalmology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Ophthalmology, Rabin Medical Center, Petah Tikva, Israel.
ORCID-Profile: Alon Harris
Förderung
- NEI NIH HHS
- NIH
- NYEE Foundation
- Research to Prevent Blindness, NY
- National Institutes of Health
Zitieren
APA
Verticchio Vercellin, A. C., Harris, A., Oddone, F., Siesky, B., Eckert, G., Belamkar, A., Antman, G., & Segev, F. (2024). Ocular blood flow biomarkers may predict long-term glaucoma progression. British Journal of Ophthalmology. https://doi.org/10.1136/bjo-2022-322644
Vancouver
Verticchio Vercellin AC, Harris A, Oddone F, Siesky B, Eckert G, Belamkar A, et al. Ocular blood flow biomarkers may predict long-term glaucoma progression. British Journal of Ophthalmology. 2024. doi:10.1136/bjo-2022-322644
BibTeX
@article{VerticchioVercellin2024,
author = {Verticchio Vercellin, Alice Chandra and Harris, Alon and Oddone, Francesco and Siesky, Brent and Eckert, George and Belamkar, Aditya and Antman, Gal and Segev, Fani},
title = {Ocular blood flow biomarkers may predict long-term glaucoma progression},
journal = {British Journal of Ophthalmology},
year = {2024},
doi = {10.1136/bjo-2022-322644}
}
EUVIMED